October 2025

Top 10 most popular cardiology video interviews this past month ()
TCT 2025 | 3D echo for pediatric patients | Medtronic launches TAVR guidewire | P‐waves help ID Black patients prone to AFib ()
Key takeaways from TCT 2025 | More good news for renal denervation | BP drug recalled | Medline files for IPO ()
First-in-human IVL data | Patient sues Abbott over heart valve | FDA clears AI-enabled plaque software | TTVR outcomes ()
The first valve replacement of its kind | Long-term data on TAVR & SAVR | New device tariffs | FDA clears AI model | Treating TR ()
Medicare now covers renal denervation | Research paused after patient’s hospitalization | Cardiologist questions Trump’s health ()
PARTNER 3 update: TAVR vs. SAVR after 7 years | Statin recall includes more than 140K bottles of pills | CRF announces merger ()
FDA clears imaging software | Planning ahead for PCI | Bringing the entire heart attack team together ()
Semaglutide & heart failure | The power of prevention | FDA approves new drug-device combination | Implant impresses ()
Biodegradable PFO closure devices | 'The less you drink, the better' | Oral health & the heart | New HF implant impresses ()
Predicting & preventing heart attacks | Carotid plaque assessments | Key FDA decisions | ICE for structural heart interventions ()
Concerns about more tariffs | ASNC looks ahead | AI-powered PCI planning | Treating eruptive calcified nodules ()
A new CPT code? | Heart patient death leads to lawsuit | Medtronic's new AI partnership | Arrested for leaving a baby alone ()
FDA confirms Class I device recall | Nuclear cardiology enters new era | Health disparities in cardio-oncology | CKM syndrome ()
Cardiologists earning more than ever | New medical device tariffs? | Trump's $100K visa fee | SCAI calls out reimbursement model ()
FDA approves oral semaglutide for reducing cardiovascular risks | PET & carotid plaque | AFib after CABG | Nonobstructive HCM ()
Week in Review: J&J devices recalled over cybersecurity risk | Pacemaker issues | Compensation hits new high | Labeling updates ()
More than 1M pacemakers recalled | A safety warning from Abbott | Q&A: What cardiologists know and don’t know about PFA ()
PFA for VT shows promise | Predicting & preventing heart attacks | FDA clears AI-powered software | SGLT2 inhibitors & TAVR ()
Cardiologist compensation hits all-time high | PET is transforming patient care | Robotic PFA | Performing PCI & TAVR together ()
ICE-guided structural heart interventions | Medtronic's new 3-in-1 stent | TTVR after a heart transplant | Shock-related deaths ()
Ross procedure continues to impress | FDA approves drug label changes | The first operation of its kind | Mental health & CVD ()
New expert guidelines on temporary MCS | A key approval | Surgeon under investigation after deaths | Surgical kits recalled ()
New Class I recalls for more than 1M pacemakers | Q&A: What we know and don’t know about PFA | A key update for Medtronic ()
Obesity drugs under review | ACC calls for more screening | Dexcom issues recall | AI delivers helpful advice | A call to action ()
FDA announces recall due to cybersecurity risk | A big issue with ACOs | Plant-based diets, dementia & CVD | A new 3-in-1 stent ()
Week in Review: TAVR fears | The top children's heart hospitals | Family sues after doctor's death | Obesity drugs under review ()
New-look robot will treat stroke, aneurysm | Leg amputation leads to lawsuit | TAVR & carotid artery stenosis ()
News Alert: FDA announces recall for Johnson & Johnson devices due to cybersecurity risk ()
Imaging trends in cardio-oncology | New FDA approvals | Patient sues hospital, cardiology practice | New surgery guidelines ()
TAVR Highlights: Cardiologists & heart surgeons sound the alarm | A key approval for Medtronic | New data on stroke risk ()
FDA clears AI model | Viz.ai launches new platform | Cardiologist death leads to lawsuit | Outrage over Trump's visa fees ()
Fighting for telehealth | Obesity drugs under review | ICE-guided interventions | A new approach at ASE 2025 | AI tech approved ()
The best of the best in children's heart health | Surgeon under investigation | New expert recommendations on treating TR ()
The best children’s heart hospitals | Expanding your CCTA program | Former CEO enters politics | Strokes & valve-in-valve TAVR ()
FDA launches investigation over injuries | New tariffs for medical devices | Trump's $100K visa fee | ASNC fights back ()
Trump's $100K visa fee is bad for patients | TAVR or SAVR? The debate continues | New Impella data | Universal screening for FH ()
New tariffs for all medical devices? | Semaglutide & high-risk patients | ACC takes on inflammation | Mavacamten falls short ()
Expert recommendations on treating tricuspid regurgitation | New registry making an impact | Patient selection & M-TEER ()
ACC takes on inflammation | Long-term data on SAVR after TAVR | Surgeon under investigation | Big news for Medtronic ()
September's Top Stories: Multiple recalls | Doctor sues hospital | A warning from Abbott | Beta blockers 'have no effect' ()
ACC, AHA outline calculation of cost-effectiveness in guidelines | Next generation Watchman LAAC device enters trial in 2026 ()
Putting more focus on prevention of heart failure | SCAI says congenital heart Medicare payments are broken | New FDA IVL trial ()